x

Fulcrum Therapeutics, Inc. (Nasdaq:FULC)

Health Care/Life Sciences • Biotechnology
CIK 1680581
Company

Fulcrum Therapeutics, Inc. is a clinical stage biopharmaceutical company. The firm develops new medicines and focuses on unlocking gene control mechanisms to develop small molecule therapies. Its product candidate includes Losmapimod and FTX-HbF. The company was founded by Michael R. Green, Danny Reinberg, Rudolf Jaenisch, Jeannie T. Lee, and Bradley E. Bernstein on August 18, 2015 and is headquartered in Cambridge, MA.

Address
26 Landsdowne Street
Cambridge, Massachusetts 02139
Employees
76
Stock Info
Close
$3.2500
Day Range
3.2300 - 3.4100
52 Week Range
2.8600 - 12.4000
Average volume
702.89K
Short Interest
4.44M (02/14/25)
% of Float Shorted
9.29%
Market Cap
$175.43M
Revenue
$2.81M
Net Income
-$97.34M
2020 Sales Growth
N/A
Rev. per Employee
N/A
P/E Ratio
N/A
EPS
-$0.2168
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
President, Chief Executive Officer & Director
Alexander C. Sapir
Director
Robert J. Gould
Chairman
Kathryn Haviland
Independent Director
Sonja L. Banks
Independent Director
R. Alan B. Ezekowitz
Independent Director
Katina Dorton
Independent Director
James Arthur Geraghty
Independent Director
Rachel K. King
Independent Director
Colin C. Hill
SEC filings
DateFormEvent
6 Dec, 2024 SC 13G
14 Nov, 2024 3
14 Nov, 2024 4
14 Nov, 2024 SC 13G/A
14 Nov, 2024 SC 13G/A
14 Nov, 2024 SCHEDULE 1
13 Nov, 2024 8-K
13 Nov, 2024 10-Q
12 Nov, 2024 SC 13G/A
12 Nov, 2024 8-K
8 Nov, 2024 SC 13G
4 Nov, 2024 SC 13G/A
21 Oct, 2024 SC 13G
7 Oct, 2024 SC 13G/A
24 Sep, 2024 8-K
23 Sep, 2024 3
20 Sep, 2024 SC 13G
16 Sep, 2024 SC 13G/A
12 Sep, 2024 8-K
23 Aug, 2024 SC 13G/A
23 Aug, 2024 4
22 Aug, 2024 8-K
31 Jul, 2024 8-K
31 Jul, 2024 10-Q
31 Jul, 2024 S-8
8 Jul, 2024 4
18 Jun, 2024 4
18 Jun, 2024 4
18 Jun, 2024 4
18 Jun, 2024 4
18 Jun, 2024 4
18 Jun, 2024 4
18 Jun, 2024 4
18 Jun, 2024 3
18 Jun, 2024 4
17 Jun, 2024 8-K
13 May, 2024 10-Q
13 May, 2024 8-K
9 May, 2024 4
25 Apr, 2024 EFFECT
24 Apr, 2024 CORRESP
19 Apr, 2024 DEF 14A
19 Apr, 2024 DEFA14A
19 Apr, 2024 ARS
20 Mar, 2024 4
20 Mar, 2024 3
8 Mar, 2024 144
8 Mar, 2024 4
5 Mar, 2024 4
1 Mar, 2024 UPLOAD
27 Feb, 2024 10-K
27 Feb, 2024 S-3
27 Feb, 2024 S-8
27 Feb, 2024 8-K
14 Feb, 2024 SC 13G/A
14 Feb, 2024 SC 13G/A
14 Feb, 2024 SC 13G/A
13 Feb, 2024 SC 13G/A
9 Feb, 2024 SC 13G/A
7 Feb, 2024 SC 13G/A
30 Jan, 2024 4
30 Jan, 2024 4
30 Jan, 2024 4
7 Nov, 2023 8-K
7 Nov, 2023 10-Q
2 Oct, 2023 8-K
22 Aug, 2023 8-K
9 Aug, 2023 4
9 Aug, 2023 3
3 Aug, 2023 8-K CEO Change
3 Aug, 2023 10-Q
10 Jul, 2023 8-K
7 Jul, 2023 SC 13G/A
3 Jul, 2023 3
29 Jun, 2023 4
29 Jun, 2023 4
29 Jun, 2023 4
29 Jun, 2023 4
29 Jun, 2023 4
29 Jun, 2023 4
29 Jun, 2023 4
26 Jun, 2023 10-K/A
26 Jun, 2023 10-K/A
23 Jun, 2023 10-K/A
9 Jun, 2023 8-K
15 May, 2023 10-Q
15 May, 2023 8-K CEO Change
11 May, 2023 4
28 Apr, 2023 DEFA14A
28 Apr, 2023 4
28 Apr, 2023 4
28 Apr, 2023 ARS
28 Apr, 2023 DEF 14A
18 Apr, 2023 PRE 14A
5 Apr, 2023 8-K
9 Mar, 2023 S-8
9 Mar, 2023 8-K
9 Mar, 2023 10-K
6 Mar, 2023 SC 13G
14 Feb, 2023 SC 13G/A
14 Feb, 2023 SC 13G/A
14 Feb, 2023 SC 13G/A
13 Feb, 2023 4
13 Feb, 2023 SC 13G/A
13 Feb, 2023 4
13 Feb, 2023 4
13 Feb, 2023 4
9 Feb, 2023 SC 13G/A
9 Feb, 2023 SC 13G/A
1 Feb, 2023 SC 13G/A
24 Jan, 2023 4
23 Jan, 2023 SC 13G/A
18 Jan, 2023 8-K
18 Jan, 2023 424B5
17 Jan, 2023 424B5
17 Jan, 2023 8-K
13 Jan, 2023 4
6 Jan, 2023 SC 13G/A
6 Jan, 2023 4
4 Jan, 2023 8-K CEO Change
29 Dec, 2022 4
21 Dec, 2022 4
16 Dec, 2022 4
15 Dec, 2022 4
9 Nov, 2022 3
9 Nov, 2022 4
8 Nov, 2022 10-Q
8 Nov, 2022 8-K
19 Oct, 2022 8-K
26 Aug, 2022 SC 13G
26 Aug, 2022 3
23 Aug, 2022 8-K
17 Aug, 2022 424B5
17 Aug, 2022 8-K
15 Aug, 2022 424B5
11 Aug, 2022 4
11 Aug, 2022 10-Q
11 Aug, 2022 3
11 Aug, 2022 4
11 Aug, 2022 8-K
11 Aug, 2022 8-K
19 Jul, 2022 4
11 Jul, 2022 8-K
29 Jun, 2022 4
29 Jun, 2022 4
29 Jun, 2022 4
29 Jun, 2022 4
29 Jun, 2022 4
29 Jun, 2022 4
29 Jun, 2022 4
22 Jun, 2022 SC 13G
10 Jun, 2022 8-K
9 Jun, 2022 8-K
8 Jun, 2022 4
6 Jun, 2022 8-K
6 Jun, 2022 4
10 May, 2022 8-K
10 May, 2022 424B5
10 May, 2022 4
9 May, 2022 POS EX
9 May, 2022 8-K
9 May, 2022 10-Q
28 Apr, 2022 DEFA14A
28 Apr, 2022 EFFECT
28 Apr, 2022 DEF 14A
11 Apr, 2022 4
5 Apr, 2022 4
14 Mar, 2022 3
10 Mar, 2022 8-K
10 Mar, 2022 SC 13G
9 Mar, 2022 SC 13G
3 Mar, 2022 POS AM
3 Mar, 2022 S-8
3 Mar, 2022 8-K
3 Mar, 2022 POSASR
3 Mar, 2022 10-K
14 Feb, 2022 SC 13G/A
14 Feb, 2022 SC 13G/A
11 Feb, 2022 SC 13G/A
9 Feb, 2022 SC 13G/A
4 Feb, 2022 SC 13G
27 Jan, 2022 S-8
21 Jan, 2022 4
21 Jan, 2022 4
21 Jan, 2022 4
21 Jan, 2022 4
21 Jan, 2022 4
10 Jan, 2022 3
10 Jan, 2022 8-K
10 Jan, 2022 4
7 Jan, 2022 5
4 Jan, 2022 8-K
9 Dec, 2021 4
9 Dec, 2021 3
6 Dec, 2021 8-K
17 Nov, 2021 8-K
12 Nov, 2021 4
12 Nov, 2021 4
4 Nov, 2021 10-Q
4 Nov, 2021 8-K
4 Nov, 2021 S-3ASR
27 Sep, 2021 SC 13G/A
24 Sep, 2021 4
24 Sep, 2021 4
10 Sep, 2021 SC 13G/A
12 Aug, 2021 8-K
12 Aug, 2021 4
12 Aug, 2021 424B5
12 Aug, 2021 4
11 Aug, 2021 S-3MEF
11 Aug, 2021 424B5
10 Aug, 2021 SC 13G
10 Aug, 2021 10-Q
10 Aug, 2021 8-K
29 Jun, 2021 4
29 Jun, 2021 4
29 Jun, 2021 4
29 Jun, 2021 4
24 Jun, 2021 8-K
11 Jun, 2021 8-K
11 Jun, 2021 4
11 Jun, 2021 4
11 Jun, 2021 4
11 Jun, 2021 4
11 Jun, 2021 4
11 Jun, 2021 4
12 May, 2021 4
12 May, 2021 3
6 May, 2021 8-K
6 May, 2021 10-Q
29 Apr, 2021 DEFA14A
29 Apr, 2021 DEF 14A
2 Apr, 2021 3
2 Apr, 2021 4
2 Apr, 2021 4
24 Mar, 2021 8-K
22 Mar, 2021 SEC STAFF
17 Mar, 2021 4
4 Mar, 2021 S-8
4 Mar, 2021 10-K
4 Mar, 2021 8-K CEO Change
24 Feb, 2021 4
22 Feb, 2021 SEC STAFF
18 Feb, 2021 4
16 Feb, 2021 SC 13G/A
16 Feb, 2021 SC 13G/A
12 Feb, 2021 SC 13G/A
11 Feb, 2021 SC 13G/A
10 Feb, 2021 4
10 Feb, 2021 3
8 Feb, 2021 SC 13G/A
4 Feb, 2021 4
27 Jan, 2021 4
27 Jan, 2021 4
25 Jan, 2021 4
22 Jan, 2021 4
20 Jan, 2021 424B5
20 Jan, 2021 8-K
19 Jan, 2021 424B5
19 Jan, 2021 8-K
Last update:2025-03-06 13:29:28.175680
Fulcrum Therapeutics, Inc. by TradingView

Sign Up to Subscribe